|
SRI expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.40659999999338E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.387900E-04 |
| Normal-vs-Stage2 |
2.292000E-01 |
| Normal-vs-Stage3 |
1.19740000004143E-06 |
| Normal-vs-Stage4 |
1.190290E-02 |
| Stage1-vs-Stage2 |
5.224200E-01 |
| Stage1-vs-Stage3 |
5.505900E-02 |
| Stage1-vs-Stage4 |
6.619600E-01 |
| Stage2-vs-Stage3 |
9.737800E-02 |
| Stage2-vs-Stage4 |
4.328400E-01 |
| Stage3-vs-Stage4 |
3.371800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.71770000004334E-06 |
| Normal-vs-AfricanAmerican |
8.728400E-01 |
| Normal-vs-Asian |
7.020600E-01 |
| Caucasian-vs-AfricanAmerican |
2.026500E-02 |
| Caucasian-vs-Asian |
6.423800E-02 |
| AfricanAmerican-vs-Asian |
7.051000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.355790E-04 |
| Normal-vs-Female |
1.603580E-04 |
| Male-vs-Female |
4.742200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.216700E-03 |
| Normal-vs-Age(41-60Yrs) |
1.640740E-04 |
| Normal-vs-Age(61-80Yrs) |
1.82455999999664E-05 |
| Normal-vs-Age(81-100Yrs) |
6.725900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.346600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.063590E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.681200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.607000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.300600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.344600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.2019999999976E-05 |
| Classical-VS-Follicular |
7.514600E-01 |
| Classical-VS-Other |
7.995000E-01 |
| Classical-VS-Normal |
1.216600E-03 |
| Tall-VS-Follicular |
5.881200E-03 |
| Tall-VS-Other |
4.609600E-01 |
| Tall-VS-Normal |
1.95270000169501E-09 |
| Follicular-VS-Other |
8.577400E-01 |
| Follicular-VS-Normal |
2.349800E-02 |
| Other-VS-Normal |
4.077000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.002900E-04 |
| Normal-vs-N1 |
2.823500E-03 |
| N0-vs-N1 |
4.570400E-01 |
|
|
